AU2008275978B9 - Compositions and methods to detect TMPRSS2/ERG transcript variants in prostate cancer - Google Patents

Compositions and methods to detect TMPRSS2/ERG transcript variants in prostate cancer Download PDF

Info

Publication number
AU2008275978B9
AU2008275978B9 AU2008275978A AU2008275978A AU2008275978B9 AU 2008275978 B9 AU2008275978 B9 AU 2008275978B9 AU 2008275978 A AU2008275978 A AU 2008275978A AU 2008275978 A AU2008275978 A AU 2008275978A AU 2008275978 B9 AU2008275978 B9 AU 2008275978B9
Authority
AU
Australia
Prior art keywords
seq
oligonucleotide
amplification
sequence
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2008275978A
Other languages
English (en)
Other versions
AU2008275978B2 (en
AU2008275978A1 (en
Inventor
Paul M. Darby
Jo Ann Jackson
Kumar Kastury
Siobhan M. Miick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gen Probe Inc
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Publication of AU2008275978A1 publication Critical patent/AU2008275978A1/en
Application granted granted Critical
Publication of AU2008275978B2 publication Critical patent/AU2008275978B2/en
Publication of AU2008275978B9 publication Critical patent/AU2008275978B9/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2008275978A 2007-07-18 2008-07-17 Compositions and methods to detect TMPRSS2/ERG transcript variants in prostate cancer Expired - Fee Related AU2008275978B9 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95039007P 2007-07-18 2007-07-18
US60/950,390 2007-07-18
PCT/US2008/070334 WO2009012387A2 (en) 2007-07-18 2008-07-17 Compositions and methods to detect tmprss2/erg transcript variants in prostate cancer

Publications (3)

Publication Number Publication Date
AU2008275978A1 AU2008275978A1 (en) 2009-01-22
AU2008275978B2 AU2008275978B2 (en) 2014-09-11
AU2008275978B9 true AU2008275978B9 (en) 2014-11-20

Family

ID=40260376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008275978A Expired - Fee Related AU2008275978B9 (en) 2007-07-18 2008-07-17 Compositions and methods to detect TMPRSS2/ERG transcript variants in prostate cancer

Country Status (6)

Country Link
US (1) US20100196903A1 (enExample)
EP (1) EP2179049A4 (enExample)
JP (1) JP5622570B2 (enExample)
AU (1) AU2008275978B9 (enExample)
CA (1) CA2693973A1 (enExample)
WO (1) WO2009012387A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11105808B2 (en) 2004-11-12 2021-08-31 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer
WO2011037936A2 (en) * 2009-09-24 2011-03-31 Oregon Health & Science University Detection of dna methylation of tal1, erg and/or cd40 to diagnose prostate cancer
EP3448998B1 (en) * 2016-04-27 2020-06-03 Gen-Probe Incorporated Blood cell lysis reagent

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541308A (en) * 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
CA2135073C (en) * 1992-05-06 2002-11-19 Daniel L. Kacian Nucleic acid sequence amplification method, composition and kit
WO2000001850A2 (en) * 1998-07-02 2000-01-13 Gen-Probe Incorporated Molecular torches
US20030073623A1 (en) * 2001-07-30 2003-04-17 Drmanac Radoje T. Novel nucleic acid sequences obtained from various cDNA libraries
CA2931751A1 (en) * 2001-11-02 2003-05-15 Gen-Probe Incorporated Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
JP4457001B2 (ja) * 2002-05-31 2010-04-28 セクレタリー・デパートメント・オブ・アトミック・エナジー ドナー／アクセプター部分が相補鎖上となる標的核酸検出のｍｅｔ／ｆｒｅｔに基づく方法
EP2292801B1 (en) * 2002-06-14 2018-08-08 Gen-Probe Incorporated Compositions and methods for detecting hepatitis b virus
EP2977470B1 (en) * 2002-10-16 2018-01-03 Gen-Probe Incorporated Compositions and methods for detecting west nile virus
AU2005245815B2 (en) * 2004-05-07 2011-06-09 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
US7696337B2 (en) * 2004-08-27 2010-04-13 Gen-Probe Incorporated Composition kits and methods for performing amplification reactions
US7718369B2 (en) * 2005-09-12 2010-05-18 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US20100087330A1 (en) * 2007-01-26 2010-04-08 Brian Leyland-Jones Breast cancer gene array

Also Published As

Publication number Publication date
JP2010533497A (ja) 2010-10-28
US20100196903A1 (en) 2010-08-05
EP2179049A2 (en) 2010-04-28
WO2009012387A2 (en) 2009-01-22
EP2179049A4 (en) 2011-07-06
WO2009012387A3 (en) 2009-03-26
CA2693973A1 (en) 2009-01-22
JP5622570B2 (ja) 2014-11-12
AU2008275978B2 (en) 2014-09-11
AU2008275978A1 (en) 2009-01-22

Similar Documents

Publication Publication Date Title
EP2640854B1 (en) PCAT1 ncRNA AND USES THEREOF
AU2011274789B2 (en) Diagnosis and treatment of breast cancer
EP1592809B1 (en) Method to detect prostate cancer in a sample
EP2478120B1 (en) Recurrent gene fusions in prostate cancer
CN110317875A (zh) 一种与肺癌相关的甲基化基因及其检测试剂盒
US20110318742A1 (en) Micro rna markers for colorectal cancer
KR101573467B1 (ko) 방광암 특이적 후성유전적 마커 유전자를 이용한 방광암의 검출방법
US20180340235A1 (en) Methods for the detection, visualization and high resolution physical mapping of genomic rearrangements in breast and ovarian cancer genes and loci brca1 and brca2 using genomic morse code in conjunction with molecular combing
EP3458614A1 (en) Methods of detecting a mutated gene by multiplex digital pcr
AU2008275978B9 (en) Compositions and methods to detect TMPRSS2/ERG transcript variants in prostate cancer
US10167517B2 (en) MIPOL1-ETV1 gene rearrangements
CN111788317B (zh) 用于表征癌症的组合物和方法
EP2898093B1 (en) Method for detection of braf and pi 3k mutations
JP2013081448A (ja) 遺伝子変異検出用プローブ
KR102816628B1 (ko) 대사증후군 특이적 후성유전 메틸화 마커 및 이의 용도
KR20120124033A (ko) 유전자 변이 검출용 프로브, 유전자 변이 검출 방법 및 유전자 변이 검출용 시약 키트
CN101517080A (zh) 肥胖基因扩增用引物对、含有其的肥胖基因扩增用试剂及其用途
WO2002015770A2 (en) Methods of cancer prognosis and assessment

Legal Events

Date Code Title Description
SREP Specification republished
MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee